SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001140361-23-048880
Filing Date
2023-10-19
Accepted
2023-10-19 16:48:36
Documents
1
Effectiveness Date
2023-10-19

Document Format Files

Seq Description Document Type Size
1 15-12G ef20012855_1512g.htm 15-12G 9556
  Complete submission text file 0001140361-23-048880.txt   10684
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-37526 | Film No.: 231335199
SIC: 2834 Pharmaceutical Preparations